“…Using adenoviral mutants, we identified two early viral proteins, E4-ORF1 and E4-ORF4, which stimulate the activity of mTOR in distinct but complementary ways. 5 One of these viral proteins, E4-ORF1, uses a C terminal PDZ binding motif to activate PI3-kinase, a well known regulator of mTOR activity. However, an E4-ORF1 mutant virus that fails to activate PI3-kinase in infected primary cells is only partially compromised in its ability to activate p70 S6K .…”